Condylox Gel 0.5% (pokofilox)

Company
Oclassen Pharmaceuticals

Approval Status
Approved March 1997

Treatment for
external genital and perianal warts

Areas
Dermatology / Plastic Surgery , Immune System

Condylox Gel 0.5% (pokofilox) has been approved for the treatment of external genital and perianal warts (condyloma acuminata). It is believed that Condylox Gel offers two important advancements over the topical solution: easy, finger-tip application and an expanded perianal wart indication.

Condylox Gel 0.5% (pokofilox) Drug Information

The Condylox Gel 0.5% (pokofilox) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top